-
Neurocrine Biosciences (NASDAQ:NBIX) Given "Overweight" Rating at Piper Sandler
来源: Buzz FX / 23 12月 2024 09:31:12 America/Chicago
Neurocrine Biosciences (NASDAQ:NBIX) Given "Overweight" Rating at Piper Sandler Written by MarketBeat December 23, 2024 Share Link copied to clipboard. Neurocrine Biosciences ( NASDAQ:NBIX - Get Free Report ) 's stock had its "overweight" r
Read more...